Canada Launches C$10.5M Prenatal Testing Comparative Effectiveness Project | GenomeWeb

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

NEW YORK (GenomeWeb News) – Researchers at Canada's CHU de Quebec and the University of Laval will use C$10.5 million (US$10.2 million) in government funding to work with Ariosa Diagnostics to run a comparative study of non-invasive prenatal testing techniques for screening for chromosomal conditions such as Down syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.